Autoimmune Pediatric CNS Disorders, CSF
Ordering Recommendation
Use to evaluate subacute-onset encephalopathy, epilepsy, behavior changes, or movement disorders in individuals <18 years of age.
Testing in both serum and CSF is recommended to maximize diagnostic yield; refer to Autoimmune Pediatric CNS Disorders, Serum (3006210) for serum testing.
New York DOH Approval Status
Specimen Required
N/A
CSF
Transfer three 1 mL CSF aliquots to ARUP standard transport tubes. (Min: 0.5 mL/aliquot)
Frozen
Fluid other than CSF. Grossly hemolyzed specimens.
After separation from cells: Ambient: 24 hours; Refrigerated: 1 week; Frozen: 30 days (avoid repeated freeze/thaw cycles)
Methodology
Semi-Quantitative Cell-Based Indirect Fluorescent Antibody/Semi-Quantitative Indirect Fluorescent Antibody (IFA)/Semi-Quantitative Enzyme-Linked Immunosorbent Assay (ELISA)
Performed
Varies
Reported
3-10 days
Reference Interval
Test Number |
Components |
Reference Interval |
---|---|---|
mGluR1 Ab IgG CBA-IFA Screen, CSF | Less than 1:1 | |
Glutamic Acid Decarboxylase Antibody CSF | 0.0-5.0 IU/mL | |
LGI1 Ab IgG CBA-IFA Screen, CSF | Less than 1:1 | |
NMDA Receptor Ab IgG CBA-IFA, CSF | Less than 1:1 | |
NMO/AQP4 Ab IgG CBA-IFA Screen, CSF | Less than 1:1 | |
CASPR2 Ab IgG CBA-IFA Screen, CSF | Less than 1:1 | |
GABA-BR Ab IgG CBA-IFA Screen, CSF | Less than 1:1 | |
DPPX Ab IgG CBA-IFA Screen, CSF | Less than 1:1 | |
GABA-AR Ab IgG CBA-IFA Screen, CSF | Less than 1:1 | |
Paraneoplastic Abs (PCCA/ANNA) IgG, CSF | None Detected |
Interpretive Data
Refer to report.
Laboratory Developed Test (LDT)
Note
If NMDA CSF antibody IgG is positive, then titer will be performed. Additional charges apply.
PCCA/ANNA antibody IgG is screened by IFA. If the IFA screen is indeterminate, then a Neuronal Nuclear Antibodies (Hu and Tr/DNER) IgG by Immunoblot will be performed. If the IFA screen is positive at 1:10 or greater, then a PCCA/ANNA antibodies titer and Neuronal Nuclear Antibodies (Hu and Tr/DNER) IgG by Immunoblot will be performed. Additional charges apply.
If LGI1 CSF antibody IgG is positive, then titer will be added. Additional charges apply.
If CASPR2 CSF antibody IgG is positive, then titer will be added. Additional charges apply.
If AQP4/NMO CSF antibody IgG by IFA is positive, then titer will be added. Additional charges apply.
If GABA-BR CSF antibody IgG by IFA is positive, then titer will be added. Additional charges apply.
If DPPX CSF antibody IgG by IFA is positive, then titer will be added. Additional charges apply.
If mGluR1 CSF antibody IgG by IFA is positive, then titer will be added. Additional charges apply.
If GABA-AR CSF antibody IgG by IFA is positive, then titer will be added. Additional charges apply.
Hotline History
Hotline History
CPT Codes
86341; 86052; 86255 x8; if reflexed add 84182 x2; 86256 per titer
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
2005165 | NMDA Receptor Ab IgG CBA-IFA, CSF | 80220-7 |
2010842 | Paraneoplastic Abs (PCCA/ANNA) IgG, CSF | 14247-1 |
2011700 | NMO/AQP4 Ab IgG CBA-IFA Screen, CSF | 46718-3 |
3001268 | GABA-BR Ab IgG CBA-IFA Screen, CSF | 82984-6 |
3001987 | CASPR2 Ab IgG CBA-IFA Screen, CSF | 90820-2 |
3001991 | LGI1 Ab IgG CBA-IFA Screen, CSF | 90830-1 |
3002789 | Glutamic Acid Decarboxylase Antibody CSF | 42501-7 |
3004513 | DPPX Ab IgG CBA-IFA Screen, CSF | 94283-9 |
3006004 | GABA-AR Ab IgG CBA-IFA Screen, CSF | |
3006040 | mGluR1 Ab IgG CBA-IFA Screen, CSF | 93500-7 |
Aliases
- Acute disseminated encephalomyelitis
- ADEM
- ANNA
- Anti-neuronal nuclear antibody
- AQP4
- Aquaporin 4
- CASPR2
- Child
- Contactin-associated protein-like-2
- Dipeptidyl aminopeptidase-like protein 6
- DPPX
- Encephalitis
- Encephalopathy
- epilepsy
- GABA-A
- GABA-AR
- GABA-B
- GABA-BR
- GAD65
- Glutamic acid decarboxylase
- Leucine-rich glioma inactivated protein-1
- LGI1
- metabotropic glutamate receptor 1
- mGluR1
- Myelitis
- Myelopathy
- NMDA
- NMDA-R